GLP-1: therapeutic revolution or excessive hype? Current facts and issues
11 novembre 2025
What is GLP-1? From the laboratory to the patient: mechanisms and promises GlP-1 agonists (aGLP-1) today embody a decisive medical advance: they act at the interface of weight control and glycemic balance, relying on the incretin effect, the essential hormonal signal that regulates our energy balance. These molecules can now be found in the daily
When the hormone GLP-1 becomes a drug: the little-known effects and challenges of a medical revolution
11 novembre 2025
The medical rise of GLP-1 analogues: background, discoveries and promise The discovery of GLP-1 (glucagon-like peptide-1), an essential intestinal hormonal messenger in the management of glycemia and eating behavior, came to light in the late 1980s. This substance, released by the digestive tract just after food ingestion, stimulates insulin production while curbing glucagon production. Pioneers
GLP-1: From intestinal hormone to new therapeutic target for obesity
11 novembre 2025
Understanding GLP-1 and its physiological role GLP-1 (glucagon-like peptide-1) is a peptide hormone secreted by the gut when food is ingested. At the crossroads of metabolic pathways, it performs several key functions: regulating blood glucose by stimulating insulin secretion, slowing gastric emptying, and modulating the sensation of satiety – three elements that together participate in
The rise of GLP-1 agonists: a scientific response to the challenges of diabetes and obesity
11 novembre 2025
Understanding GLP-1 and its analogues: mechanisms and distinctive properties Glucagon-like peptide 1 (GLP-1) has established itself as a pivotal player in metabolic research and the pharmacological treatment of type 2 diabetes and obesity. This incretin hormone, secreted by intestinal L cells after each food intake, modulates blood glucose levels by stimulating insulin release from beta
Ozempic: understanding drugs, their uses and supervision
20 octobre 2025
Ozempic overview: definition, composition and presentation Ozempic is one of the major injectable treatments in the GLP-1 analog class, pharmacological reference A10BJ06. Developed by Novo Nordisk, it is aimed exclusively at adults with type 2 diabetes. Its active ingredient, semaglutide, is a synthetic peptide designed to mimic glucagon-like peptide-1 (GLP-1). This mechanism stimulates insulin secretion,
Ozempic : comprendre le médicament, ses usages et son encadrement
20 octobre 2025
Panorama d’Ozempic : définition, composition et présentation Ozempic figure parmi les traitements injectables majeurs de la classe des analogues du GLP-1, référence pharmacologique A10BJ06. Développé par Novo Nordisk, il s’adresse exclusivement aux adultes souffrant de diabète de type 2. Son principe actif, le semaglutide, est un peptide synthétique conçu pour imiter le glucagon-like peptide-1 (GLP-1). Ce
Stop Smoking Restorative Sleep: Effective Strategies for Better Sleep
2 mai 2025
Sleep and smoking cessation: a silent crisis with alarming consequences The consequences of smoking cessation are not limited to the often-mentioned physical symptoms. A lesser-known facet, but just as destabilizing, is the disruption to sleep. Insomnia, nightmares or frequent awakenings: giving up smoking can become a real night-time ordeal. Why do these problems occur? And
Arrêt tabac sommeil réparateur : Stratégies Efficaces pour un Sommeil Meilleur
2 mai 2025
Sommeil et arrêt du tabac : une crise silencieuse aux conséquences alarmantes Les conséquences de l’arrêt du tabac ne se limitent pas aux symptômes physiques souvent évoqués. Une facette moins connue, mais tout aussi déstabilisante, est le bouleversement du sommeil. Insomnie, cauchemars ou réveils fréquents : le sevrage tabagique peut devenir une véritable épreuve nocturne.
Ils ont perdu 10 kg en quelques semaines grâce au GLP-1 : mythe ou réalité ?
29 avril 2025
ILS ONT PERDU 10 KG EN QUELQUES SEMAINES GRÂCE AU GLP-1 : MYTHE OU RÉALITÉ ? Envie de maigrir rapidement sans passer par des régimes interminables ? Glp-1, ça vous parle ? Ces médicaments, comme le très médiatisé sémaglutide, font miroiter des pertes de poids spectaculaires allant jusqu’à 10 kg en quelques semaines. Trop beau
Ozempic, Wegovy: the secret weapon against excess weight?
28 avril 2025
OZEMPIC, WEGOVY: THE SECRET ARM AGAINST TOO MANY KILOS? EVERYTHING ABOUT THE MEDICINAL OBESITY REVOLUTION Did you know that almost 39% of adults worldwide struggle with overweight or obesity? Unexpected, but the future of the fight against those extra kilos seems to lie with a needle. Drugs like Ozempic and Wegovy are redefining traditional approaches